Here’s a very supportive Twitter posting from the leader of Stanford’s Pain Management efforts: Sean Mackey, MD, PhD. (@DrSeanMackey) on Oct 22, 2019
This is a breath of fresh air! Coming from an influential leader in the pain management field at a high-status University, I have hope that it will get through to some of our tormentors.
1) I’d like to share this brief story about a patient who’s currently taking opioids.
2) We’ve been treating a patient at Stanford who has a lower extremity injury. He came to us on high-doses of opioids through fentanyl patches.
His primary care doctor wanted him weaned off. He has tried every treatment imaginable.
And why did his primary doctor want him weaned off? The rest of this little story shows that there were no medical reasons to take the patient off opioids. Continue reading
AMA: Get rid of market barriers to appropriate pain management – by Andis Robeznieks – Senior News Writer – American Medical Association
This article makes a critical point and describes what should be the goal when treating pain: “appropriate analgesic prescribing and pain management.”
Ending the nation’s opioid epidemic requires eliminating obstacles to treatment and appropriate analgesic prescribing and pain management.
New policies adopted at the 2019 AMA Annual Meeting took aim at barriers established by health plans and other players in the medical system. Continue reading
Outcomes After Opioid Dose Reductions and Stoppage: It’s Time to Start Counting – Stefan G. Kertesz, MD, MSc – Aug 2019
As clinicians reconsidered the value of a muchoversold drug class [opioids], the institutions that govern, regulate, pay, and police health care pushed for reductions.
The unanswered question[s] would be
- how such reductions would be carried out,
- who might measure the outcomes, and
- whether those outcomes included benefits, harms, or both.
And into that chasm of deliberate blindness are falling the suicides of pain patients who cannot live with their pain untreated.
The authors of the CDC’s opioid guidelines say they’ve been misapplied – By ANDREW JOSEPH @DrewQJoseph and ED SILVERMAN @Pharmalot – Apr 2019
The authors of influential federal guidelines for opioid prescriptions for chronic pain said Wednesday that doctors and others in the health care system had wrongly implemented their recommendations and cut off patients who should have received pain medication.
They said some health care players had used the guidelines to justify an “inflexible application of recommended dosage and duration thresholds and policies that encourage hard limits and abrupt tapering of drug dosages,” when the guidelines did not actually endorse those policies.
The new paper comes three years [of unrelieved agony and suicides] after the Centers for Disease Control and Prevention published the prescribing guideline. Continue reading
Preventing Opioid Abuse Shouldn’t Mean Ignoring Patients’ Pain – by Subhash Jain – Aug 2019
I’m surprised and delighted that this article was published in the respected “Harvard Business Review” so that it reaches the people making the rules from their seats in the executive suites of medical corporations.
From lawsuits by several states against the manufacturers of opioids to criminal prosecutions against pharmaceutical executives, much has been made about pain medications and their misuse. Unfortunately, if you just pay attention to these headlines, you’re likely to miss an important fact:
Pain medications are an important and medically necessary part of many patients’ treatment.
Hurrah, another doctor pushing back against the widespread policies of reducing long term opioid use to almost zero. Continue reading
Are Rx Opioids the Culprits or Scapegoats for Opioid Crisis? — Pain News Network – By Dr. Lynn Webster, PNN Columnist – Aug 2019
The Washington Post recently published a series of stories about the volume of opioid medication distributed over the past several years in the United States. Over 76 billion pills were distributed from 2002 through 2012.
That sounds like a huge amount, but it is difficult to know what the number means. What is clear is that the stories are meant to suggest the number of pills is excessive and responsible for the rise in opioid overdose deaths.
It sickens me to see how the media sensationalizes the huge numbers of individual pills without putting them into context. Continue reading
Opioid moderatism and the imperative of rapprochement in pain medicine – free full-text /PMC6388760/ – by,, and – J Pain Res. Feb 2019
A brief history of the “prescription opioid crisis”
Although many have attempted to blame this crisis on a single cause, more thoughtful analysis has yielded numerous contributors to the onset and maintenance of the abuse crisis.
health insurance carriers’ decision to discontinue coverage of interdisciplinary pain management programs left physicians without the most effective means of treating chronic pain, resulting in the consequence of turning to increased opioid prescribing.
There are many in the pain community who will not acknowledge this dubious conjecture. I don’t really believe it either but will concede the point if it allows us to initiate a dialog with the “opposition”. Continue reading
OPIOID FACTS: Are we getting the whole picture? “A Physician’s Perspective” – by medium.com/@ThomasKlineMD/ – Jun 2019
This is an article in quasi-interview format by Dr. Kline, who is also tracking the damage done by the “unintended consequences” of the CDC guideline with a list of SUICIDES associated with forced tapering of opiate pain treatments
Q: Is there an epidemic of opioid overdose deaths?
The actual increase from 2014 to 2015 was in line with years past, a 0.001% increase. These are street overdose deaths in addiction communities, not in the general public. No particular year was statistically higher than another. Continue reading
National Imperative to Align Practice and Policy with the Actual CDC Opioid Guideline – by Beth Darnall, PhD – July 23, 2019
Here’s another article by Dr. Darnall arguing against the rigid anti-opioid sentiment she previously seemed to support when she claimed that much of chronic pain was due to “catastrophizing”.
This year (2019) she has completely reversed course to push back against the fallout from her previous stance. I admire her courage in so publicly attacking the anti-opioid sentiment that was encouraged by her previous stance.
Although the national focus on opioid reduction preceded the CDC guideline [2016 CDC Guideline for Prescribing Opioids for Chronic Pain], its issuance emboldened opioid reduction practices and policies in ways that its authors never intended. Continue reading
Opioid discontinuation as an institutional mandate: Questions and answers on why we wrote to the Centers for Disease Control and Prevention: Substance Abuse: Vol 40, No 1 – Stefan Kertesz, MD – May 2019
This article explains what the HP3 group wanted to accomplish with their letter “protesting” the CDC guideline. It looks like it worked!
On March 6, 2019, a self-designated committee (Health Professionals for Patients in Pain, HP3, a group that is not incorporated and accepts no contributions) sent a public letter to the Centers for Disease Control and Prevention (CDC), urging the agency to address the widespread misapplication of its 2016 guideline on prescribing opioids.
318 health care professionals and three former directors of the White House Office of National Drug Control Policy (“Drug Czars”) signed the letter, as did the parent organization for Substance Abuse, the Association for Multidisciplinary Education and Research on Substance use and Addiction. Continue reading